Find your next M&A target
Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.
Project details
Japanese non-invasive blood glucose detection technology company seeks financing.
| Project region | Japan |
|---|---|
| Industry | Biomedicine |
| Total value of the target | N/A |
| Expected target net rate of return after deducting all taxes and fees | N/A |
| Validity period of pending order | 365 |
CONTACT ADVISOR
Simon Laube
Assistant Manager, International Business Advisory
| Project highlights | intelligent wearable device technology supplier - spectrometer - USD 10 million financing obtained |
|---|---|
| Project description |
The Japanese company is an intelligent wearable device technology supplier, which can provide detection solutions for blood pressure, heartbeat, body temperature, blood oxygen and other physical characteristics. The non-interventional blood glucose detection developed by the company can use the spectrometer to measure the blood glucose level of users in a non-invasive manner. At present, the company has obtained USD 10 million financing from Taisho Pharmaceutical Group and Alfresa Holdings Corporation. Now it seeks financing. |
Enquire for more information about our services, and how we can help solve challenges for your organization
Contact Us